These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 6772373

  • 21. [Comparative therapeutic activity of rifampicin and isoniazid in different densities of microbial population in the lungs of experimental animals].
    Sodikov ES, Ismatullaev F.
    Probl Tuberk; 1986; (6):50-3. PubMed ID: 3092209
    [No Abstract] [Full Text] [Related]

  • 22. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA, Ursov IG.
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract] [Full Text] [Related]

  • 23. Experimental and clinical studies of rifampicin in tuberculosis.
    Konno K, Oizumi K, Hayashi I, Oka S.
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):110-20. PubMed ID: 5004309
    [No Abstract] [Full Text] [Related]

  • 24. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H, Watanabe Y, Yamanaka M, Moriguchi T, Fujii K, Uenoyama T.
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract] [Full Text] [Related]

  • 25. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [Abstract] [Full Text] [Related]

  • 26. [Initial pulmonary tuberculosis treated with the isoniazid-rifampicin combination and followed after cessation of treatment].
    Oury M, Tuchais E, Viallet S, Chauvet G.
    Rev Tuberc Pneumol (Paris); 1971 Dec; 35(8):819-28. PubMed ID: 5151119
    [No Abstract] [Full Text] [Related]

  • 27. [On the lability of the degree of drug resistance of Mycobacterium tuberculosis strains].
    Belogurova VP.
    Antibiotiki; 1967 Aug; 12(8):718-22. PubMed ID: 4968418
    [No Abstract] [Full Text] [Related]

  • 28. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
    Kuz'min AV, Vasil'eva IA, Chernousova LN.
    Probl Tuberk Bolezn Legk; 2006 Aug; (8):17-23. PubMed ID: 17002052
    [Abstract] [Full Text] [Related]

  • 29. Drug resistance among tuberculosis patients, New York City, 1991 and 1992.
    Driver CR, Frieden TR, Bloch AB, Onorato IM.
    Public Health Rep; 1994 Aug; 109(5):632-6. PubMed ID: 7938383
    [Abstract] [Full Text] [Related]

  • 30. [Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
    Pavlova MV, Skvortsova LA, Kondakova MN, Sapozhnikova NV.
    Probl Tuberk Bolezn Legk; 2004 Aug; (1):24-6. PubMed ID: 15137140
    [Abstract] [Full Text] [Related]

  • 31. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B, Keo C, Leng C, Saman M, Min DC, Chan S, Monchy D, Sarthou JL.
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [Abstract] [Full Text] [Related]

  • 32. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS, Gupta S, Lal S.
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [Abstract] [Full Text] [Related]

  • 33. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
    Krüüner A, Pehme L, Ghebremichael S, Koivula T, Hoffner SE, Mikelsaar M.
    Clin Infect Dis; 2002 Jul 15; 35(2):146-55. PubMed ID: 12087520
    [Abstract] [Full Text] [Related]

  • 34. Within-host population dynamics of antibiotic-resistant M. tuberculosis.
    Alavez-Ramírez J, Castellanos JR, Esteva L, Flores JA, Fuentes-Allen JL, García-Ramos G, Gómez G, López-Estrada J.
    Math Med Biol; 2007 Mar 15; 24(1):35-56. PubMed ID: 17060491
    [Abstract] [Full Text] [Related]

  • 35. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
    Skotnikova OI, Galkina KIu, Nosova EIu, Krasnova MA, Moroz AM.
    Probl Tuberk Bolezn Legk; 2005 Mar 15; (8):42-5. PubMed ID: 16209020
    [Abstract] [Full Text] [Related]

  • 36. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS, Jamieson F, Chedore P, Haddad A, Vernich L.
    Clin Infect Dis; 2000 Aug 15; 31(2):427-32. PubMed ID: 10987700
    [Abstract] [Full Text] [Related]

  • 37. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK, Kim CT, Song SD.
    Int J Tuberc Lung Dis; 1998 Nov 15; 2(11):877-84. PubMed ID: 9848607
    [Abstract] [Full Text] [Related]

  • 38. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA, Voloshina EP, Adamovich NV, Maslakova MG, Terekhova ND.
    Probl Tuberk Bolezn Legk; 2005 Nov 15; (12):37-9. PubMed ID: 16496762
    [Abstract] [Full Text] [Related]

  • 39. [Bacterial isolation during chemotherapy of patients with pulmonary tuberculosis].
    Afanas'eva IuP, Kuznetsova VI.
    Probl Tuberk; 1977 Dec 15; (12):32-6. PubMed ID: 416433
    [No Abstract] [Full Text] [Related]

  • 40. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M, Ouedraogo SM, Diagbouga S, Coulibaly G, Achi V, Domoua K, N'Dathz M, Yapi A.
    Rev Mal Respir; 2000 Apr 15; 17(2):477-80. PubMed ID: 10859766
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.